Molecular chaperones: cancer dependence and druggability
19 Jan 2011
Molecular chaperones: cancer dependence and druggability
World Health Organisation cancer prevention and control
The European Academy of Cancer Sciences
ESTRO 2010 - Snapshots from the conference
ESTRO 2010 Highlights
The role of the B-RAF mutation in melanoma treatment
Advances in the treatment of melanoma
Advances in melanoma treatment
Biotherapy Development Association
Roundup of the 2010 ASCO conference
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma
European Association for Cancer Research